Jun 3 |
CNS Pharmaceuticals announces reverse stock split
|
Jun 3 |
CNS Pharmaceuticals Announces Reverse Stock Split
|
May 20 |
CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
|
May 16 |
CNS Pharmaceuticals reports Q1 results
|
May 16 |
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
|
May 9 |
CNS Pharmaceuticals files for $75M mixed shelf offering
|
Apr 23 |
CNS Pharmaceuticals to Present at the LSX World Congress 2024
|
Apr 22 |
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
|